Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles B Scott

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04)Jeffrey D Bradley, Charles B Scott, Kristie J Paris, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07)Darlene J Johnson, Charles B Scott, James E Marks, et al.
Journal for Immunotherapy of Cancer|August 7, 2023
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastomaChristopher Cultrara, Christopher Uhl, Kenneth Kirby, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018William F Regine, Frederick A Schmitt, Charles B Scott, et al.
Travel Medicine and Infectious Disease|November 21, 2021
Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trialAnne Novitt-Moreno, Adam Martidis, Victor Gonzalez, et al.
Journal of Child Neurology|September 1, 2007
Perspectives on clinical trials in spinal muscular atrophyKathryn J Swoboda, John T Kissel, Thomas O Crawford, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
Journal of the National Cancer Institute|June 2, 2005
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastasesWilliam F Hartsell, Charles B Scott, Deborah Watkins Bruner, et al.
Plos One|May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Plos One|September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04)Jeffrey D Bradley, Charles B Scott, Kristie J Paris, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07)Darlene J Johnson, Charles B Scott, James E Marks, et al.
Journal for Immunotherapy of Cancer|August 7, 2023
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastomaChristopher Cultrara, Christopher Uhl, Kenneth Kirby, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018William F Regine, Frederick A Schmitt, Charles B Scott, et al.
Travel Medicine and Infectious Disease|November 21, 2021
Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trialAnne Novitt-Moreno, Adam Martidis, Victor Gonzalez, et al.
Journal of Child Neurology|September 1, 2007
Perspectives on clinical trials in spinal muscular atrophyKathryn J Swoboda, John T Kissel, Thomas O Crawford, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
Journal of the National Cancer Institute|June 2, 2005
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastasesWilliam F Hartsell, Charles B Scott, Deborah Watkins Bruner, et al.
Plos One|May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Plos One|September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
Pageof 3